Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quanwu Zhang

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Therapeutics|July 26, 2005
Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sampleQuanwu Zhang, Laura Menditto
Diabetes Care|January 30, 2007
Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetesAaron I Vinik, Quanwu Zhang
Medicine|September 15, 2023
Prognostic significance of MALAT1 in clear cell renal cell carcinoma based on TCGA and GEOKai Liu, Yingxue Gao, Quanwu Zhang
American Journal of Therapeutics|November 24, 2006
Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management programAthena Philis-Tsimikas, Quanwu Zhang, Chris Walker
The Journal of Prevention of Alzheimer'S Disease|June 8, 2025
Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementiaBabak Haji, Quanwu Zhang, Amir Abbas Tahami Monfared
Neuroimmunomodulation|October 10, 2002
Immunological variables mediate cognitive dysfunction in gulf war veterans but not civilians with chronic fatigue syndromeMichael Brimacombe, QuanWu Zhang, Gudrun Lange, et al.
Clinical Therapeutics|July 12, 2014
Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in JapanAkihiro Hosaka, Tetsuro Miyata, Yoshie Onishi, et al.
Neurology and Therapy|January 31, 2022
Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data AnalysisAmir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, et al.
Molecular Medicine Reports|October 2, 2018
Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathwaysJuan Zhang, Lihua Guo, Quanwu Zhang, et al.
Neurology and Therapy|April 15, 2023
Understanding Barriers Along the Patient Journey in Alzheimer's Disease Using Social Media DataAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Therapeutics|July 26, 2005
Incremental cost savings 6 months following initiation of insulin glargine in a Medicaid fee-for-service sampleQuanwu Zhang, Laura Menditto
Diabetes Care|January 30, 2007
Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetesAaron I Vinik, Quanwu Zhang
Medicine|September 15, 2023
Prognostic significance of MALAT1 in clear cell renal cell carcinoma based on TCGA and GEOKai Liu, Yingxue Gao, Quanwu Zhang
American Journal of Therapeutics|November 24, 2006
Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management programAthena Philis-Tsimikas, Quanwu Zhang, Chris Walker
The Journal of Prevention of Alzheimer'S Disease|June 8, 2025
Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementiaBabak Haji, Quanwu Zhang, Amir Abbas Tahami Monfared
Neuroimmunomodulation|October 10, 2002
Immunological variables mediate cognitive dysfunction in gulf war veterans but not civilians with chronic fatigue syndromeMichael Brimacombe, QuanWu Zhang, Gudrun Lange, et al.
Clinical Therapeutics|July 12, 2014
Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in JapanAkihiro Hosaka, Tetsuro Miyata, Yoshie Onishi, et al.
Neurology and Therapy|January 31, 2022
Staging Disease Severity Using the Alzheimer's Disease Composite Score (ADCOMS): A Retrospective Data AnalysisAmir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, et al.
Molecular Medicine Reports|October 2, 2018
Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathwaysJuan Zhang, Lihua Guo, Quanwu Zhang, et al.
Neurology and Therapy|April 15, 2023
Understanding Barriers Along the Patient Journey in Alzheimer's Disease Using Social Media DataAmir Abbas Tahami Monfared, Yaakov Stern, Stephen Doogan, et al.
Pageof 7